Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,420.80
+22.10 (1.58%)
Feb 16, 2026, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 237.42 billion as of February 13, 2026. Its market cap has increased by 6.25% in one year.
Market Cap
237.42B
Enterprise Value
226.31B
Revenue
26.63B
Ranking
n/a
PE Ratio
44.92
Stock Price
1,420.80
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 237.42B, an increase of 248.22%. That is a compound annual growth rate of 13.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 237.42B | -4.17% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.07T |
| Divi's Laboratories | 1.64T |
| Apollo Hospitals Enterprise | 1.08T |
| Cipla | 1.08T |
| Emcure Pharmaceuticals | 282.22B |
| Inventurus Knowledge Solutions | 281.52B |
| Krishna Institute of Medical Sciences | 274.98B |
| Pfizer | 230.45B |